Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors

Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors

Ovarian cancer treatment strategy is mainly based on three pillars: cytoreductive surgery, platinum-based chemotherapy, and targeted therapies. The latter in the last decade has provided a remarkable improvement in progression free patients and, hopefully, in overall survival. In particular, poly(ad...

Full description

Bibliographic Details
Main Authors: Camilla Nero, Francesca Ciccarone, Antonella Pietragalla, Simona Duranti, Gennaro Daniele, Vanda Salutari, Maria Vittoria Carbone, Giovanni Scambia, Domenica Lorusso
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
ovarian cancer
PARP inhibitors
immunotherapy
targeted therapy
Online Access:https://www.mdpi.com/2072-6694/13/6/1298

Internet

https://www.mdpi.com/2072-6694/13/6/1298

Similar Items